Literature DB >> 24319094

Prognosis and management of chronic kidney disease (CKD) at the end of life.

Rachel Davison1, Neil S Sheerin.   

Abstract

The prevalence of chronic kidney disease (CKD) increases with age. As people are living longer, nephrologists are responsible for a progressively older cohort of patients with substantial comorbidities. Patients with CKD have a significant symptom burden and can benefit from intervention and symptom control from an early stage in the illness. It is also increasingly recognised that renal replacement therapy may not always offer an improvement in symptoms or a survival advantage to older patients with high levels of comorbidity. For these reasons, non-dialytic (conservative) management and end-of-life care is becoming part of routine nephrology practice. Such patients will also frequently be encountered in other specialities, requiring generalists to have some renal-specific skills and knowledge. Although there have been significant advances in this field in recent years, the optimum model of care and some of the care preferences of patients remain challenges that need to be addressed.

Entities:  

Mesh:

Year:  2013        PMID: 24319094     DOI: 10.1136/postgradmedj-2013-132195

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  Advance care planning: a qualitative study of dialysis patients and families.

Authors:  Sarah L Goff; Nwamaka D Eneanya; Rebecca Feinberg; Michael J Germain; Lisa Marr; Joan Berzoff; Lewis M Cohen; Mark Unruh
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-13       Impact factor: 8.237

2.  Perceptions of prognostic risks in chronic kidney disease: a national survey.

Authors:  Helen H L Chiu; Navdeep Tangri; Ognjenka Djurdjev; Brendan J Barrett; Brenda R Hemmelgarn; François Madore; Claudio Rigatto; Norman Muirhead; Manish M Sood; Catherine M Clase; Adeera Levin
Journal:  Can J Kidney Health Dis       Date:  2015-12-20

3.  End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases.

Authors:  Steven M Brunelli; Christopher M Blanchette; Ami J Claxton; Debosree Roy; Sandro Rossetti; Benjamin Gutierrez
Journal:  Clinicoecon Outcomes Res       Date:  2015-01-06

4.  External validation and clinical utility of a prediction model for 6-month mortality in patients undergoing hemodialysis for end-stage kidney disease.

Authors:  Brian Forzley; Lee Er; Helen H L Chiu; Ognjenka Djurdjev; Dan Martinusen; Rachel C Carson; Gaylene Hargrove; Adeera Levin; Mohamud Karim
Journal:  Palliat Med       Date:  2017-07-21       Impact factor: 4.762

5.  A Survey of Canadian Nephrologists Assessing Prognostication in End-Stage Renal Disease.

Authors:  Brian Forzley; Helen H L Chiu; Ognjenka Djurdjev; Rachel C Carson; Gaylene Hargrove; Dan Martinusen; Mohamud Karim
Journal:  Can J Kidney Health Dis       Date:  2017-08-18

6.  Longitudinal changes in nutritional parameters and resting energy expenditure in end-stage renal disease.

Authors:  Mariana Cassani Oliveira; Marina Nogueira Berbel Bufarah; Daniela Ponce; André Balbi
Journal:  J Bras Nefrol       Date:  2019-10-24

7.  Perceptions of patients with end-stage kidney disease (ESKD) and their informal caregivers on palliative care as a treatment option: a qualitative study.

Authors:  Catherine Sarfo-Walters; Edward Appiah Boateng
Journal:  BMC Palliat Care       Date:  2020-08-20       Impact factor: 3.234

8.  Association of Self-Rated Health With Functional Limitations in Patients With CKD.

Authors:  Jacqueline Lee; Khaled Abdel-Kader; Jonathan G Yabes; Manqi Cai; Hsin-Hsiung Chang; Manisha Jhamb
Journal:  Kidney Med       Date:  2021-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.